Prostate cancer

PSA velocity in prostate cancer screening-the debate continues

Michael S Borofsky, Danil V. Makarov

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Prostate cancer screening in the PSA era is controversial and the most appropriate measures for diagnosis are widely debated. Vickers and colleagues recently suggested that using PSA velocity in screening offers little benefit compared with traditional markers; however, elimination of this test from practice or guidelines may be premature.

Original languageEnglish (US)
Pages (from-to)413-414
Number of pages2
JournalNature Reviews Urology
Volume8
Issue number8
DOIs
StatePublished - Aug 1 2011
Externally publishedYes

Fingerprint

Early Detection of Cancer
Practice Guidelines
Prostatic Neoplasms

Cite this

Prostate cancer : PSA velocity in prostate cancer screening-the debate continues. / Borofsky, Michael S; Makarov, Danil V.

In: Nature Reviews Urology, Vol. 8, No. 8, 01.08.2011, p. 413-414.

Research output: Contribution to journalReview article

@article{e7702e07494e49ad8a89d07ba6d258f3,
title = "Prostate cancer: PSA velocity in prostate cancer screening-the debate continues",
abstract = "Prostate cancer screening in the PSA era is controversial and the most appropriate measures for diagnosis are widely debated. Vickers and colleagues recently suggested that using PSA velocity in screening offers little benefit compared with traditional markers; however, elimination of this test from practice or guidelines may be premature.",
author = "Borofsky, {Michael S} and Makarov, {Danil V.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1038/nrurol.2011.87",
language = "English (US)",
volume = "8",
pages = "413--414",
journal = "Nature Reviews Urology",
issn = "1759-4812",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Prostate cancer

T2 - PSA velocity in prostate cancer screening-the debate continues

AU - Borofsky, Michael S

AU - Makarov, Danil V.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Prostate cancer screening in the PSA era is controversial and the most appropriate measures for diagnosis are widely debated. Vickers and colleagues recently suggested that using PSA velocity in screening offers little benefit compared with traditional markers; however, elimination of this test from practice or guidelines may be premature.

AB - Prostate cancer screening in the PSA era is controversial and the most appropriate measures for diagnosis are widely debated. Vickers and colleagues recently suggested that using PSA velocity in screening offers little benefit compared with traditional markers; however, elimination of this test from practice or guidelines may be premature.

UR - http://www.scopus.com/inward/record.url?scp=80051680310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051680310&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2011.87

DO - 10.1038/nrurol.2011.87

M3 - Review article

VL - 8

SP - 413

EP - 414

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

IS - 8

ER -